Sign up to save your podcasts
Or
Share Impact of the plasma shortage and the Human-to-Human Connection: Ft Megan Ryan, Primary Immune Deficiency Disease Advocate
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Impact of the plasma shortage and the Human-to-Human Connection: Ft Megan Ryan, Primary Immune Deficiency Disease Advocate
The FDA’s formal announcement of a plasma shortage capped a rising issue that was foreseen a couple years back. This announcement took plasma last August and is now followed by the onset of Covid-19 to start 2020. It’s easy to excuse these setbacks as a bottom-line issue for bio-pharma companies but doing so would miss the human element. Plasma derived therapies depend on a human-to-human connection; that starts with a donor at a plasma center.
View all episodes
By iPlasma StudiosThe FDA’s formal announcement of a plasma shortage capped a rising issue that was foreseen a couple years back. This announcement took plasma last August and is now followed by the onset of Covid-19 to start 2020. It’s easy to excuse these setbacks as a bottom-line issue for bio-pharma companies but doing so would miss the human element. Plasma derived therapies depend on a human-to-human connection; that starts with a donor at a plasma center.